Home > > > > Report Detail

Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 22-Sep-2022
No. of pages: 134
Inquire Before Buying

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Human Vaccine market is projected to reach US$ 44100 million by 2028 from an estimated US$ 33590 million in 2022, at a CAGR of 4.6% during 2023 and 2028.

In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.

East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.

In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Human Vaccine.

The Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Human Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- CNBG

- Changsheng Life

- Zhifei

- ChengDa Bio

- Kangtai

- SINOVAC BIOTECH

- Hissen

- Walvax Biotechnology

- GSK

- SANOFI

- Rong An

- NuoCheng Bio

- Hualan Bio

- Tiantan biological

- Changchun Baike

- Adimmune

- Zhongyianke Biotech

- Bharat Biotech

- Bavarian Nordic

- Sanofi-Pasteur

- Indian Immunologicals

- KANGH

- Henan Grand Biopharma

- ZhongKe Biopharm

- Zhuoyi Biological

Product Type Insights

Global markets are presented by Human Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Human Vaccine are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Human Vaccine Segment by Type

- Varicella

- Influenza

- Polio

- Hepatitis A

- Rabies

- BCG

- Hepatitis B

- Pertussis, Diphtheria, Tetanus

- Pneumococcal

- Rota vaccine

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Human Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Vaccine market.

Human Vaccine Segment by Application

- Adults

- Children

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Human Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Human Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Vaccine industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Human Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market by Application
1.3.1 Global Human Vaccine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Market Size Estimates and Forecasts
2.1.1 Global Human Vaccine Revenue 2017-2028
2.1.2 Global Human Vaccine Sales 2017-2028
2.2 Human Vaccine Market Size by Region: 2022 Versus 2028
2.3 Human Vaccine Sales by Region (2017-2028)
2.3.1 Global Human Vaccine Sales by Region: 2017-2022
2.3.2 Global Human Vaccine Sales Forecast by Region (2023-2028)
2.3.3 Global Human Vaccine Sales Market Share by Region (2017-2028)
2.4 Human Vaccine Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Human Vaccine Revenue by Region: 2017-2022
2.4.2 Global Human Vaccine Revenue Forecast by Region (2023-2028)
2.4.3 Global Human Vaccine Revenue Market Share by Region (2017-2028)
3 Global Human Vaccine by Manufacturers
3.1 Global Top Human Vaccine Manufacturers by Sales
3.1.1 Global Human Vaccine Sales by Manufacturer (2017-2022)
3.1.2 Global Human Vaccine Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Human Vaccine Manufacturers by Revenue
3.2.1 Global Human Vaccine Revenue by Manufacturer (2017-2022)
3.2.2 Global Human Vaccine Revenue Share by Manufacturer (2017-2022)
3.3 Global Human Vaccine Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Human Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Vaccine Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Human Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CNBG
4.1.1 CNBG Corporation Information
4.1.2 CNBG Description, Business Overview
4.1.3 CNBG Human Vaccine Products Offered
4.1.4 CNBG Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.1.5 CNBG Human Vaccine Sales by Product in 2021
4.1.6 CNBG Human Vaccine Sales by Application in 2021
4.1.7 CNBG Human Vaccine Sales by Geographic Area in 2021
4.1.8 CNBG Recent Developments
4.2 Changsheng Life
4.2.1 Changsheng Life Corporation Information
4.2.2 Changsheng Life Description, Business Overview
4.2.3 Changsheng Life Human Vaccine Products Offered
4.2.4 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Changsheng Life Human Vaccine Sales by Product in 2021
4.2.6 Changsheng Life Human Vaccine Sales by Application in 2021
4.2.7 Changsheng Life Human Vaccine Sales by Geographic Area in 2021
4.2.8 Changsheng Life Recent Developments
4.3 Zhifei
4.3.1 Zhifei Corporation Information
4.3.2 Zhifei Description, Business Overview
4.3.3 Zhifei Human Vaccine Products Offered
4.3.4 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Zhifei Human Vaccine Sales by Product in 2021
4.3.6 Zhifei Human Vaccine Sales by Application in 2021
4.3.7 Zhifei Human Vaccine Sales by Geographic Area in 2021
4.3.8 Zhifei Recent Developments
4.4 ChengDa Bio
4.4.1 ChengDa Bio Corporation Information
4.4.2 ChengDa Bio Description, Business Overview
4.4.3 ChengDa Bio Human Vaccine Products Offered
4.4.4 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.4.5 ChengDa Bio Human Vaccine Sales by Product in 2021
4.4.6 ChengDa Bio Human Vaccine Sales by Application in 2021
4.4.7 ChengDa Bio Human Vaccine Sales by Geographic Area in 2021
4.4.8 ChengDa Bio Recent Developments
4.5 Kangtai
4.5.1 Kangtai Corporation Information
4.5.2 Kangtai Description, Business Overview
4.5.3 Kangtai Human Vaccine Products Offered
4.5.4 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Kangtai Human Vaccine Sales by Product in 2021
4.5.6 Kangtai Human Vaccine Sales by Application in 2021
4.5.7 Kangtai Human Vaccine Sales by Geographic Area in 2021
4.5.8 Kangtai Recent Developments
4.6 SINOVAC BIOTECH
4.6.1 SINOVAC BIOTECH Corporation Information
4.6.2 SINOVAC BIOTECH Description, Business Overview
4.6.3 SINOVAC BIOTECH Human Vaccine Products Offered
4.6.4 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.6.5 SINOVAC BIOTECH Human Vaccine Sales by Product in 2021
4.6.6 SINOVAC BIOTECH Human Vaccine Sales by Application in 2021
4.6.7 SINOVAC BIOTECH Human Vaccine Sales by Geographic Area in 2021
4.6.8 SINOVAC BIOTECH Recent Development
4.7 Hissen
4.7.1 Hissen Corporation Information
4.7.2 Hissen Description, Business Overview
4.7.3 Hissen Human Vaccine Products Offered
4.7.4 Hissen Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Hissen Human Vaccine Sales by Product in 2021
4.7.6 Hissen Human Vaccine Sales by Application in 2021
4.7.7 Hissen Human Vaccine Sales by Geographic Area in 2021
4.7.8 Hissen Recent Development
4.8 Walvax Biotechnology
4.8.1 Walvax Biotechnology Corporation Information
4.8.2 Walvax Biotechnology Description, Business Overview
4.8.3 Walvax Biotechnology Human Vaccine Products Offered
4.8.4 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Walvax Biotechnology Human Vaccine Sales by Product in 2021
4.8.6 Walvax Biotechnology Human Vaccine Sales by Application in 2021
4.8.7 Walvax Biotechnology Human Vaccine Sales by Geographic Area in 2021
4.8.8 Walvax Biotechnology Recent Development
4.9 GSK
4.9.1 GSK Corporation Information
4.9.2 GSK Description, Business Overview
4.9.3 GSK Human Vaccine Products Offered
4.9.4 GSK Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.9.5 GSK Human Vaccine Sales by Product in 2021
4.9.6 GSK Human Vaccine Sales by Application in 2021
4.9.7 GSK Human Vaccine Sales by Geographic Area in 2021
4.9.8 GSK Recent Development
4.10 SANOFI
4.10.1 SANOFI Corporation Information
4.10.2 SANOFI Description, Business Overview
4.10.3 SANOFI Human Vaccine Products Offered
4.10.4 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.10.5 SANOFI Human Vaccine Sales by Product in 2021
4.10.6 SANOFI Human Vaccine Sales by Application in 2021
4.10.7 SANOFI Human Vaccine Sales by Geographic Area in 2021
4.10.8 SANOFI Recent Development
4.11 Rong An
4.11.1 Rong An Corporation Information
4.11.2 Rong An Description, Business Overview
4.11.3 Rong An Human Vaccine Products Offered
4.11.4 Rong An Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Rong An Human Vaccine Sales by Product in 2021
4.11.6 Rong An Human Vaccine Sales by Application in 2021
4.11.7 Rong An Human Vaccine Sales by Geographic Area in 2021
4.11.8 Rong An Recent Development
4.12 NuoCheng Bio
4.12.1 NuoCheng Bio Corporation Information
4.12.2 NuoCheng Bio Description, Business Overview
4.12.3 NuoCheng Bio Human Vaccine Products Offered
4.12.4 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.12.5 NuoCheng Bio Human Vaccine Sales by Product in 2021
4.12.6 NuoCheng Bio Human Vaccine Sales by Application in 2021
4.12.7 NuoCheng Bio Human Vaccine Sales by Geographic Area in 2021
4.12.8 NuoCheng Bio Recent Development
4.13 Hualan Bio
4.13.1 Hualan Bio Corporation Information
4.13.2 Hualan Bio Description, Business Overview
4.13.3 Hualan Bio Human Vaccine Products Offered
4.13.4 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Hualan Bio Human Vaccine Sales by Product in 2021
4.13.6 Hualan Bio Human Vaccine Sales by Application in 2021
4.13.7 Hualan Bio Human Vaccine Sales by Geographic Area in 2021
4.13.8 Hualan Bio Recent Development
4.14 Tiantan biological
4.14.1 Tiantan biological Corporation Information
4.14.2 Tiantan biological Description, Business Overview
4.14.3 Tiantan biological Human Vaccine Products Offered
4.14.4 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Tiantan biological Human Vaccine Sales by Product in 2021
4.14.6 Tiantan biological Human Vaccine Sales by Application in 2021
4.14.7 Tiantan biological Human Vaccine Sales by Geographic Area in 2021
4.14.8 Tiantan biological Recent Development
4.15 Changchun Baike
4.15.1 Changchun Baike Corporation Information
4.15.2 Changchun Baike Description, Business Overview
4.15.3 Changchun Baike Human Vaccine Products Offered
4.15.4 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Changchun Baike Human Vaccine Sales by Product in 2021
4.15.6 Changchun Baike Human Vaccine Sales by Application in 2021
4.15.7 Changchun Baike Human Vaccine Sales by Geographic Area in 2021
4.15.8 Changchun Baike Recent Development
4.16 Adimmune
4.16.1 Adimmune Corporation Information
4.16.2 Adimmune Description, Business Overview
4.16.3 Adimmune Human Vaccine Products Offered
4.16.4 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Adimmune Human Vaccine Sales by Product in 2021
4.16.6 Adimmune Human Vaccine Sales by Application in 2021
4.16.7 Adimmune Human Vaccine Sales by Geographic Area in 2021
4.16.8 Adimmune Recent Development
4.17 Zhongyianke Biotech
4.17.1 Zhongyianke Biotech Corporation Information
4.17.2 Zhongyianke Biotech Description, Business Overview
4.17.3 Zhongyianke Biotech Human Vaccine Products Offered
4.17.4 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.17.5 Zhongyianke Biotech Human Vaccine Sales by Product in 2021
4.17.6 Zhongyianke Biotech Human Vaccine Sales by Application in 2021
4.17.7 Zhongyianke Biotech Human Vaccine Sales by Geographic Area in 2021
4.17.8 Zhongyianke Biotech Recent Development
4.18 Bharat Biotech
4.18.1 Bharat Biotech Corporation Information
4.18.2 Bharat Biotech Description, Business Overview
4.18.3 Bharat Biotech Human Vaccine Products Offered
4.18.4 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.18.5 Bharat Biotech Human Vaccine Sales by Product in 2021
4.18.6 Bharat Biotech Human Vaccine Sales by Application in 2021
4.18.7 Bharat Biotech Human Vaccine Sales by Geographic Area in 2021
4.18.8 Bharat Biotech Recent Development
4.19 Bavarian Nordic
4.19.1 Bavarian Nordic Corporation Information
4.19.2 Bavarian Nordic Description, Business Overview
4.19.3 Bavarian Nordic Human Vaccine Products Offered
4.19.4 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.19.5 Bavarian Nordic Human Vaccine Sales by Product in 2021
4.19.6 Bavarian Nordic Human Vaccine Sales by Application in 2021
4.19.7 Bavarian Nordic Human Vaccine Sales by Geographic Area in 2021
4.19.8 Bavarian Nordic Recent Development
4.20 Sanofi-Pasteur
4.20.1 Sanofi-Pasteur Corporation Information
4.20.2 Sanofi-Pasteur Description, Business Overview
4.20.3 Sanofi-Pasteur Human Vaccine Products Offered
4.20.4 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.20.5 Sanofi-Pasteur Human Vaccine Sales by Product in 2021
4.20.6 Sanofi-Pasteur Human Vaccine Sales by Application in 2021
4.20.7 Sanofi-Pasteur Human Vaccine Sales by Geographic Area in 2021
4.20.8 Sanofi-Pasteur Recent Development
4.21 Indian Immunologicals
4.21.1 Indian Immunologicals Corporation Information
4.21.2 Indian Immunologicals Description, Business Overview
4.21.3 Indian Immunologicals Human Vaccine Products Offered
4.21.4 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.21.5 Indian Immunologicals Human Vaccine Sales by Product in 2021
4.21.6 Indian Immunologicals Human Vaccine Sales by Application in 2021
4.21.7 Indian Immunologicals Human Vaccine Sales by Geographic Area in 2021
4.21.8 Indian Immunologicals Recent Development
4.22 KANGH
4.22.1 KANGH Corporation Information
4.22.2 KANGH Description, Business Overview
4.22.3 KANGH Human Vaccine Products Offered
4.22.4 KANGH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.22.5 KANGH Human Vaccine Sales by Product in 2021
4.22.6 KANGH Human Vaccine Sales by Application in 2021
4.22.7 KANGH Human Vaccine Sales by Geographic Area in 2021
4.22.8 KANGH Recent Development
4.23 Henan Grand Biopharma
4.23.1 Henan Grand Biopharma Corporation Information
4.23.2 Henan Grand Biopharma Description, Business Overview
4.23.3 Henan Grand Biopharma Human Vaccine Products Offered
4.23.4 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.23.5 Henan Grand Biopharma Human Vaccine Sales by Product in 2021
4.23.6 Henan Grand Biopharma Human Vaccine Sales by Application in 2021
4.23.7 Henan Grand Biopharma Human Vaccine Sales by Geographic Area in 2021
4.23.8 Henan Grand Biopharma Recent Development
4.24 ZhongKe Biopharm
4.24.1 ZhongKe Biopharm Corporation Information
4.24.2 ZhongKe Biopharm Description, Business Overview
4.24.3 ZhongKe Biopharm Human Vaccine Products Offered
4.24.4 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.24.5 ZhongKe Biopharm Human Vaccine Sales by Product in 2021
4.24.6 ZhongKe Biopharm Human Vaccine Sales by Application in 2021
4.24.7 ZhongKe Biopharm Human Vaccine Sales by Geographic Area in 2021
4.24.8 ZhongKe Biopharm Recent Development
4.25 Zhuoyi Biological
4.25.1 Zhuoyi Biological Corporation Information
4.25.2 Zhuoyi Biological Description, Business Overview
4.25.3 Zhuoyi Biological Human Vaccine Products Offered
4.25.4 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.25.5 Zhuoyi Biological Human Vaccine Sales by Product in 2021
4.25.6 Zhuoyi Biological Human Vaccine Sales by Application in 2021
4.25.7 Zhuoyi Biological Human Vaccine Sales by Geographic Area in 2021
4.25.8 Zhuoyi Biological Recent Development
5 Breakdown Data by Type
5.1 Global Human Vaccine Sales by Type (2017-2028)
5.1.1 Global Human Vaccine Sales by Type (2017-2022)
5.1.2 Global Human Vaccine Sales Forecast by Type (2023-2028)
5.1.3 Global Human Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Human Vaccine Revenue Forecast by Type (2017-2028)
5.2.1 Global Human Vaccine Revenue by Type (2017-2022)
5.2.2 Global Human Vaccine Revenue Forecast by Type (2023-2028)
5.2.3 Global Human Vaccine Revenue Market Share by Type (2017-2028)
5.3 Human Vaccine Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Human Vaccine Sales by Application (2017-2028)
6.1.1 Global Human Vaccine Sales by Application (2017-2022)
6.1.2 Global Human Vaccine Sales Forecast by Application (2023-2028)
6.1.3 Global Human Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Human Vaccine Revenue Forecast by Application (2017-2028)
6.2.1 Global Human Vaccine Revenue by Application (2017-2022)
6.2.2 Global Human Vaccine Revenue Forecast by Application (2023-2028)
6.2.3 Global Human Vaccine Revenue Market Share by Application (2017-2028)
6.3 Human Vaccine Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Human Vaccine Market Size YoY Growth 2017-2028
7.2 North America Human Vaccine Market Facts & Figures by Country
7.2.1 North America Human Vaccine Sales by Country (2017-2028)
7.2.2 North America Human Vaccine Revenue by Country (2017-2028)
7.3 North America Human Vaccine Sales by Type
7.4 North America Human Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccine Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Human Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Human Vaccine Sales by Region (2017-2028)
8.2.2 Asia-Pacific Human Vaccine Revenue by Region (2017-2028)
8.3 Asia-Pacific Human Vaccine Sales by Type
8.4 Asia-Pacific Human Vaccine Sales by Application
9 Europe
9.1 Europe Human Vaccine Market Size YoY Growth 2017-2028
9.2 Europe Human Vaccine Market Facts & Figures by Country
9.2.1 Europe Human Vaccine Sales by Country (2017-2028)
9.2.2 Europe Human Vaccine Revenue by Country (2017-2028)
9.3 Europe Human Vaccine Sales by Type
9.4 Europe Human Vaccine Sales by Application
10 Latin America
10.1 Latin America Human Vaccine Market Size YoY Growth 2017-2028
10.2 Latin America Human Vaccine Market Facts & Figures by Country
10.2.1 Latin America Human Vaccine Sales by Country (2017-2028)
10.2.2 Latin America Human Vaccine Revenue by Country (2017-2028)
10.3 Latin America Human Vaccine Sales by Type
10.4 Latin America Human Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Human Vaccine Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Human Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Vaccine Sales by Country (2017-2028)
11.2.2 Middle East and Africa Human Vaccine Revenue by Country (2017-2028)
11.3 Middle East and Africa Human Vaccine Sales by Type
11.4 Middle East and Africa Human Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Human Vaccine Supply Chain Analysis
12.2 Human Vaccine Key Raw Materials and Upstream Suppliers
12.3 Human Vaccine Clients Analysis
12.4 Human Vaccine Sales Channel and Sales Model Analysis
12.4.1 Human Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Vaccine Distributors
13 Market Dynamics
13.1 Human Vaccine Industry Trends
13.2 Human Vaccine Market Drivers
13.3 Human Vaccine Market Challenges
13.4 Human Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Varicella
Table 3. Major Manufacturers of Influenza
Table 4. Major Manufacturers of Polio
Table 5. Major Manufacturers of Hepatitis A
Table 6. Major Manufacturers of Rabies
Table 7. Major Manufacturers of BCG
Table 8. Major Manufacturers of Hepatitis B
Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus
Table 10. Major Manufacturers of Pneumococcal
Table 11. Major Manufacturers of Rota vaccine
Table 12. Global Human Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 13. Global Human Vaccine Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 14. Global Human Vaccine Sales by Region (2017-2022) & (M Doses)
Table 15. Global Human Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 16. Global Human Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Human Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 18. Global Human Vaccine Sales by Manufacturer (2017-2022) & (M Doses)
Table 19. Global Human Vaccine Sales Share by Manufacturer (2017-2022)
Table 20. Human Vaccine Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 21. Human Vaccine Revenue Share by Manufacturer (2017-2022)
Table 22. Key Manufacturers Human Vaccine Price (2017-2022) & (USD/Dose)
Table 23. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 24. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 25. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2021)
Table 26. Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Human Vaccine Product Type
Table 28. Date of International Manufacturers Enter into Human Vaccine Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. CNBG Corporation Information
Table 31. CNBG Description and Business Overview
Table 32. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 33. CNBG Human Vaccine Product
Table 34. CNBG Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 35. CNBG Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 36. CNBG Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 37. CNBG Recent Development
Table 38. Changsheng Life Corporation Information
Table 39. Changsheng Life Description and Business Overview
Table 40. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 41. Changsheng Life Human Vaccine Product
Table 42. Changsheng Life Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 43. Changsheng Life Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 44. Changsheng Life Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 45. Changsheng Life Recent Development
Table 46. Zhifei Corporation Information
Table 47. Zhifei Description and Business Overview
Table 48. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 49. Zhifei Human Vaccine Product
Table 50. Zhifei Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 51. Zhifei Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 52. Zhifei Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 53. Zhifei Recent Development
Table 54. ChengDa Bio Corporation Information
Table 55. ChengDa Bio Description and Business Overview
Table 56. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 57. ChengDa Bio Human Vaccine Product
Table 58. ChengDa Bio Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 59. ChengDa Bio Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 60. ChengDa Bio Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 61. ChengDa Bio Recent Development
Table 62. Kangtai Corporation Information
Table 63. Kangtai Description and Business Overview
Table 64. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. Kangtai Human Vaccine Product
Table 66. Kangtai Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 67. Kangtai Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 68. Kangtai Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 69. Kangtai Recent Development
Table 70. SINOVAC BIOTECH Corporation Information
Table 71. SINOVAC BIOTECH Description and Business Overview
Table 72. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 73. SINOVAC BIOTECH Human Vaccine Product
Table 74. SINOVAC BIOTECH Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 75. SINOVAC BIOTECH Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 76. SINOVAC BIOTECH Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 77. Hissen Corporation Information
Table 78. Hissen Description and Business Overview
Table 79. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Hissen Human Vaccine Product
Table 81. Hissen Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 82. Hissen Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 83. Hissen Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 84. Walvax Biotechnology Corporation Information
Table 85. Walvax Biotechnology Description and Business Overview
Table 86. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 87. Walvax Biotechnology Human Vaccine Product
Table 88. Walvax Biotechnology Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 89. Walvax Biotechnology Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 90. Walvax Biotechnology Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 91. GSK Corporation Information
Table 92. GSK Description and Business Overview
Table 93. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 94. GSK Human Vaccine Product
Table 95. GSK Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 96. GSK Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 97. GSK Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 98. SANOFI Corporation Information
Table 99. SANOFI Description and Business Overview
Table 100. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 101. SANOFI Human Vaccine Product
Table 102. SANOFI Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 103. SANOFI Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 104. SANOFI Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 105. Rong An Corporation Information
Table 106. Rong An Description and Business Overview
Table 107. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Rong An Human Vaccine Product
Table 109. Rong An Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 110. Rong An Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 111. Rong An Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 112. NuoCheng Bio Corporation Information
Table 113. NuoCheng Bio Description and Business Overview
Table 114. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 115. NuoCheng Bio Human Vaccine Product
Table 116. NuoCheng Bio Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 117. NuoCheng Bio Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 118. NuoCheng Bio Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 119. Hualan Bio Corporation Information
Table 120. Hualan Bio Description and Business Overview
Table 121. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 122. Hualan Bio Human Vaccine Product
Table 123. Hualan Bio Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 124. Hualan Bio Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 125. Hualan Bio Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 126. Tiantan biological Corporation Information
Table 127. Tiantan biological Description and Business Overview
Table 128. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 129. Tiantan biological Human Vaccine Product
Table 130. Tiantan biological Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 131. Tiantan biological Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 132. Tiantan biological Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 133. Changchun Baike Corporation Information
Table 134. Changchun Baike Description and Business Overview
Table 135. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 136. Changchun Baike Human Vaccine Product
Table 137. Changchun Baike Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 138. Changchun Baike Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 139. Changchun Baike Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 140. Adimmune Corporation Information
Table 141. Adimmune Description and Business Overview
Table 142. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Adimmune Human Vaccine Product
Table 144. Adimmune Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
Table 145. Adimmune Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
Table 146. Adimmune Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
Table 147. Zhongyianke Biotech Corporation Information
Table 148. Zhongyianke Biotech Description and Business Overview
Table 149. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 150. Zhongyianke Biotech Human Vaccine Product
Table 151. Zhongyianke Biotech Human Vaccine Sales Proportion of Human Vaccine by Pr
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs